Back to search results

Smartphone-enabled Blood Test for Early Colorectal Cancer Detection

This study is looking at a new way to screen for colorectal cancer (CRC) using a blood test and a smartphone app. It aims to see how well people accept and stick with CRC screening when using a blood-based screening test (BBST). The study also wants to understand how often people follow up with another blood test if their first one was negative, and how a smartphone app can help people get a colonoscopy if their blood test is positive. You might be able to join if you are between 45 and 84 years old, considered average risk for CRC, and willing to provide blood samples. The study plans to enroll 5500 participants.

Study design
This study is an interventional study, meaning participants will receive an intervention. Participants will be randomly assigned to either receive educational information via a smartphone app or not.
What's involved
If you opt for the blood-based screening test, you will need to provide blood samples as instructed. The study will measure follow-up one year after your initial blood test result.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for one year after their initial blood test result.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07398456

Smartphone-enabled Hybrid Identification of Early CoLorectal Disease Using Blood-Based Cancer Testing Across TeXas

Not Yet Recruiting
NAAges 45–84InterventionalScreening
Baylor Research Institute
~5,500 participants
Updated 2026-02-12 on ClinicalTrials.gov
What's tested:Educational Information via Smartphone App

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Blood-Based Screening Test (BBST) Follow-Up
Measured over 1 year after initial result

Conditions

Colorectal Cancer (CRC) Screening

Explore related trials

Colorectal Carcinoma

Where it's being run

1 sites across 1 states
Texas1

Who to contact

Page E Blas, MA
[email protected]
214-820-5424
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

patients aged 45-84 years of age
Considered by health-care providers to be "average risk" for CRC as determined by USPSTF guidelines
If a patient opts for BBST, they are able and willing to provide blood samples per protocol
Ability to understand and the willingness to participate in the study
Must have been seen in HTPN clinic within the past 24 months from study activation
Must have active MyBSW app portal account and/or establish account during study recruitment

Exclusion

Patients with a personal history of CRC
Patients with a known high-risk family history of CRC precluding the patient from being average risk
Patients with known diagnosis of inflammatory bowel disease or history of polyps
Patients who are currently symptomatic for CRC such as: blood in the stool
Patients with any known medical condition which, in the opinion of the investigator, should preclude enrollment into the study
Have a recorded up to date CRC screening in the EMR (within 1 year for FIT, 3 years for mt-sDNA, 10 years for colonoscopy)
Patients with a previous abnormal colonoscopy finding who are due for surveillance.

What this trial measures

  • Blood-Based Screening Test (BBST) Follow-Up1 year after initial result

    Assess the number of patients with a negative BBST result who accept and complete a follow-up BBST.